Get the Stockscreener App
73.26
1.31%
-0.97
After Hours:
73.28
0.02
+0.03%
Soleno Therapeutics Inc Stock (SLNO) Forecast
The Soleno Therapeutics Inc (SLNO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $44.16, representing a -39.73% decrease from the current price of $73.26. The highest analyst price target is $66.80, and the lowest is $21.51.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SLNO Price Target
Average 53.18
(-27.41% Downside)
Is Soleno Therapeutics Inc (SLNO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 64.18 | Neutral |
| STOCH(9,6) | 90.21 | Sell |
| STOCHRSI(14) | 79.48 | Neutral |
| MACD(12,26) | 4.5406 | Sell |
| ADX(14) | 26.48 | Buy |
| William %R | -7.0898 | Sell |
| CCI(14) | 125.76 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
70.75
Buy
|
70.68
Buy
|
| MA20 |
69.37
Buy
|
67.38
Buy
|
| MA50 |
56.54
Buy
|
60.23
Buy
|
| MA100 |
52.07
Buy
|
55.57
Buy
|
| MA200 |
51.48
Buy
|
51.86
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, SLNO could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on SLNO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 64.18 indicates that SLNO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 90.21 indicates that SLNO is oversold. This means that SLNO price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 79.48 indicates that SLNO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.48 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 125.76 indicates that SLNO is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term SLNO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Soleno Therapeutics Inc financial reports and earnings history, Soleno Therapeutics Inc (SLNO) stock could reach $79.20 by 2030, $77.82 by 2040 and $117.51 by 2050. See the projected annual prices until 2050 of the Soleno Therapeutics Inc stock below:
- Soleno Therapeutics Inc (SLNO) is expected to reach an average price of $80.21 in 2035, with a high prediction of $80.54 and a low estimate of $72.51. This indicates an $9.48% rise from the last recorded price of $73.26.
- Soleno Therapeutics Inc (SLNO) stock is projected to chart a bullish course in 2040, with an average price target of $77.07, representing an $5.20% surge from its current level. The forecast ranges from a conservative $75.51 to a sky-high $77.82.
- Our analysts predict Soleno Therapeutics Inc (SLNO) to jump 30.42% by 2045, soaring from $95.41 to an average price of $95.55, potentially reaching $96.02. While $95.41 is the low estimate, the potential upside is significant.
- Soleno Therapeutics Inc (SLNO) stock is expected to climb by 2050, reaching an average of $116.79, a $59.41% jump from its current level. However, a wide range of estimates exists, with high and low targets of $117.51 and $116.04, respectively, highlighting the market's uncertainty.
Soleno Therapeutics Inc Stock (SLNO) Year by Year Forecast
Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2025
Soleno Therapeutics Inc Stock (SLNO) is expected to reach an average price of $52.92 in 2025, with a high prediction of $84.84 and a low estimate of $21.01. This indicates an -27.76% fall from the last recorded price of $73.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $59.70 | $21.51 | $66.80 | -18.50% |
| June, 2025 | $68.61 | $59.99 | $78.32 | -6.35% |
| July, 2025 | $47.92 | $42.34 | $84.84 | -34.59% |
| August, 2025 | $49.25 | $45.85 | $53.57 | -32.77% |
| September, 2025 | $46.23 | $44.10 | $49.88 | -36.90% |
| October, 2025 | $50.14 | $45.96 | $52.21 | -31.56% |
| November, 2025 | $57.32 | $46.19 | $64.67 | -21.76% |
| December, 2025 | $45.93 | $42.33 | $54.05 | -37.30% |
Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2026
The predicted value for Soleno Therapeutics Inc (SLNO) in 2026 is set at an average of $52.02. Estimates vary from a peak of $70.75 to a trough of $33.29, indicating an -28.99% surge from the present price of $73.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $48.76 | $45.22 | $51.55 | -33.44% |
| February, 2026 | $50.99 | $46.31 | $50.99 | -30.39% |
| March, 2026 | $51.57 | $47.91 | $54.89 | -29.60% |
| April, 2026 | $65.84 | $48.94 | $70.75 | -10.14% |
| May, 2026 | $44.36 | $40.73 | $66.31 | -39.44% |
| June, 2026 | $38.79 | $37.80 | $44.85 | -47.05% |
| July, 2026 | $35.37 | $34.76 | $40.24 | -51.72% |
| August, 2026 | $38.19 | $35.13 | $45.95 | -47.88% |
| September, 2026 | $36.70 | $36.10 | $39.48 | -49.91% |
| October, 2026 | $35.63 | $34.55 | $37.03 | -51.37% |
| November, 2026 | $35.07 | $33.29 | $35.94 | -52.13% |
| December, 2026 | $35.39 | $34.02 | $36.07 | -51.70% |
Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Soleno Therapeutics Inc (SLNO) is $30.00, with a high forecast of $35.33 and a low forecast of $24.67. This indicates an -59.05% decrease from the last price of $73.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $33.27 | $32.93 | $35.33 | -54.58% |
| February, 2027 | $32.74 | $32.44 | $34.26 | -55.30% |
| March, 2027 | $30.14 | $29.47 | $32.98 | -58.86% |
| April, 2027 | $28.37 | $28.02 | $30.52 | -61.27% |
| May, 2027 | $27.35 | $26.22 | $29.15 | -62.67% |
| June, 2027 | $27.03 | $26.80 | $28.56 | -63.11% |
| July, 2027 | $25.84 | $25.49 | $27.56 | -64.73% |
| August, 2027 | $25.72 | $25.53 | $26.16 | -64.89% |
| September, 2027 | $25.31 | $24.67 | $26.19 | -65.45% |
| October, 2027 | $25.25 | $25.13 | $26.38 | -65.54% |
| November, 2027 | $26.26 | $25.31 | $26.49 | -64.15% |
| December, 2027 | $26.06 | $25.57 | $27.26 | -64.42% |
Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2028
In 2028, Soleno Therapeutics Inc (SLNO) is projected to reach an average price of $27.79, with a high projection of $30.99 and a low estimate of $24.59. This indicates an -62.06% fall from the last price of $73.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $25.42 | $25.15 | $26.23 | -65.30% |
| February, 2028 | $25.13 | $25.06 | $25.82 | -65.69% |
| March, 2028 | $24.62 | $24.61 | $25.33 | -66.40% |
| April, 2028 | $24.84 | $24.59 | $25.15 | -66.10% |
| May, 2028 | $25.41 | $24.74 | $26.34 | -65.32% |
| June, 2028 | $26.52 | $25.39 | $26.75 | -63.80% |
| July, 2028 | $26.32 | $26.09 | $27.24 | -64.08% |
| August, 2028 | $26.47 | $26.05 | $26.79 | -63.87% |
| September, 2028 | $26.91 | $26.31 | $27.24 | -63.27% |
| October, 2028 | $28.48 | $26.84 | $28.71 | -61.13% |
| November, 2028 | $30.71 | $28.43 | $30.86 | -58.08% |
| December, 2028 | $29.18 | $28.75 | $30.99 | -60.17% |
Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2029
The 2029 price forecast for Soleno Therapeutics Inc Stock (SLNO) is $54.63 on average, with a high prediction of $80.31 and a low estimate of $28.94. This represents an -25.43% decrease from the previous price of $73.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $30.15 | $28.94 | $30.47 | -58.84% |
| February, 2029 | $30.22 | $29.28 | $30.60 | -58.75% |
| March, 2029 | $30.21 | $28.97 | $30.82 | -58.76% |
| April, 2029 | $49.69 | $29.30 | $55.68 | -32.17% |
| May, 2029 | $47.60 | $46.90 | $51.21 | -35.02% |
| June, 2029 | $55.56 | $47.03 | $56.15 | -24.16% |
| July, 2029 | $66.11 | $53.04 | $66.60 | -9.76% |
| August, 2029 | $72.37 | $61.60 | $74.87 | -1.21% |
| September, 2029 | $75.15 | $71.39 | $76.68 | +2.59% |
| October, 2029 | $68.33 | $63.99 | $80.01 | -6.73% |
| November, 2029 | $63.95 | $63.06 | $70.52 | -12.71% |
| December, 2029 | $64.59 | $63.57 | $80.31 | -11.84% |
Soleno Therapeutics Inc Stock (SLNO) Price Forecast for 2030
Soleno Therapeutics Inc Stock (SLNO) is expected to reach an average price of $68.68 in 2030, with a high forecast of $98.08 and a low forecast of $39.29. This signifies an -6.25% decrease from the last price of $73.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $75.37 | $61.91 | $79.20 | +2.88% |
| February, 2030 | $77.43 | $71.98 | $81.03 | +5.69% |
| March, 2030 | $66.29 | $64.04 | $80.34 | -9.52% |
| April, 2030 | $62.05 | $60.57 | $66.35 | -15.31% |
| May, 2030 | $58.02 | $56.97 | $63.89 | -20.80% |
| June, 2030 | $56.03 | $53.48 | $63.93 | -23.52% |
| July, 2030 | $59.35 | $56.24 | $60.57 | -18.98% |
| August, 2030 | $62.31 | $58.67 | $68.55 | -14.94% |
| September, 2030 | $82.37 | $39.29 | $98.08 | +12.44% |
| October, 2030 | $80.36 | $39.56 | $97.48 | +9.70% |
| November, 2030 | $69.45 | $39.86 | $88.14 | -5.19% |
| December, 2030 | $71.06 | $56.77 | $77.51 | -3.00% |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):